1. Treatment: Alpha Glucosidase Inhibitors
   Markolf Hanefeld et al, 2019, Encyclopedia of Endocrine Diseases CrossRef
2. Rapamycin, Acarbose and 17α-estradiol share common mechanisms regulating the MAPK pathways involved in intracellular signaling and inflammation
   Lily Wink et al, 2022, Immunity & Ageing CrossRef
3. The effects of acarbose treatment on cardiovascular risk factors in impaired glucose tolerance and diabetic patients: a systematic review and dose–response meta-analysis of randomized clinical trials
   Mohammad Zamani et al, 2023, Frontiers in Nutrition CrossRef
4. A comparative study of acarbose, vildagliptin and saxagliptin intended for better efficacy and safety on type 2 diabetes mellitus treatment
   Zhongchao Wang et al, 2021, Life Sciences CrossRef
5. The critical issue linking lipids and inflammation: Clinical utility of stopping oxidative stress
   Bradley Field Bale et al, 2022, Frontiers in Cardiovascular Medicine CrossRef
6. Predictors of acarbose therapeutic efficacy in newly diagnosed type 2 diabetes mellitus patients in China
   Rong Zhang et al, 2022, BMC Pharmacology and Toxicology CrossRef
7. The effects of acarbose on chemokine and cytokine production in human monocytic THP-1 cells
   Yi-Ching Lin et al, 2019, Hormones CrossRef
8. Protective effects of acarbose against vascular endothelial dysfunction through inhibiting Nox4/NLRP3 inflammasome pathway in diabetic rats
   Xiao-Xue Li et al, 2019, Free Radical Biology and Medicine CrossRef
9. Prognostic roles of diabetes mellitus and hypertension in advanced hepatocellular carcinoma treated with sorafenib
   Ming-Han Hsieh et al, 2020, PLOS ONE CrossRef
10. Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs
    Carolin Thomas et al, 2022, Frontiers in Aging CrossRef
11. The effect of short‐term intensive insulin therapy on inflammatory cytokines in patients with newly diagnosed type 2 diabetes
    Junyu He et al, 2022, Journal of Diabetes CrossRef